The global IT services company has partnered with Vantage Towers, Europe’s second-largest telecom tower operator, to launch a ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences Ltd is quoting at Rs 906.2, up 2.11% on the day as on 12:49 IST on the NSE. The stock is down 7.22% in last one year as compared to a 0.19% fall in NIFTY and a 6.32% fall in the ...

Zydus Lifesciences introduces ANVIMO, a cost-effective medication for preventing CMV infection in transplant patients, ...

Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Benchmark BSE Sensex surged by 740 points while Nifty snapped its 10-day losing streak on Wednesday (March 5) following value ...

Zydus Lifesciences is developing a combination vaccine for shigellosis and typhoid, supported by the Gates Foundation. This ...

Zydus Lifesciences to develop first combination vaccine for typhoid and shigellosis with Gates Foundation support.